Drug · DIN 02407329
XTANDI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 7, 2013; first marketed June 7, 2013.
- Drug Identification Number (DIN)
- 02407329
- Company (DIN owner)
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Enzalutamide L02BB04
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ENZALUTAMIDE | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 29, 2013: NOC 14409New Drug Submission (NDS)